Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New ultrasound test aims to detect muscle wasting in kidney transplant patients

NCT ID NCT07607236

First seen May 26, 2026 · Last updated Jun 23, 2026 · Updated 6 times

Summary

This study will check if a muscle ultrasound can reliably detect muscle loss (sarcopenia) in 140 adults getting a kidney transplant. Researchers will compare ultrasound results with a standard body-composition test before and up to one year after transplant. If it works, this could offer a quick, noninvasive way to monitor muscle health in these patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, 610072, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could provide a simple, radiation-free way to diagnose muscle wasting in kidney transplant patients, improving early detection and management.

What could go wrong

This is an early observational study with only 140 participants at one center. The ultrasound method may not prove accurate enough to replace current techniques.

Conditions

The condition(s) this trial relates to.

Frailty muscular atrophy Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.